Study Provides Scaffold to Selectively Target Drug Breakdown Process
Scientists at St. Jude Children鈥檚 Research Hospital explored selectively blocking the CYP3A4 protein responsible for breaking down large swaths of approved drugs, providing a way to improve drug efficacy.
10-Apr-2025 8:05 PM EDT
Add to Favorites